Roland Staud, MD, FACP, FACR Professor of Medicine Division of Rheumatology and Clinical Immunology University of Florida Gainesville, FL Peter Barland, MD (CCME Reviewer) Professor Emeritus, Departments of Medicine and Pathology Albert Einstein College of Medicine of Yeshiva University New York, NY
An interactive CME-certified interactive newsletter series on management considerations for fibromyalgia in the primary care setting.
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, affecting mostly women between the ages of 20 and 55. Fibromyalgia is becoming better understood as a syndrome with neurological connections. Evidence suggests that it is part of a continuum of disorders referred to as central sensitivity syndromes, which involve central nervous system sensory amplification. Despite increasing awareness of the disorder, fibromyalgia remains under-diagnosed and undertreated.
To achieve better health outcomes and quality of life for patients with fibromyalgia, primary care clinicians must achieve competency in recognizing the condition and establishing an optimal tailored treatment approach for each patient. The goal of this continuing education activity is to expand the ability of primary care practitioners and other clinicians to treat fibromyalgia based on each patient's individual characteristics. Program Developer/Facilitator
This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.
This interactive newsletter series is designed to meet the needs of primary care physicians and other providers who care for patients with fibromyalgia.
Upon completion of this educational activity, the participant should be able to:
Differentiate the indications, safety, and efficacy of pharmacologic agents used for the treatment of fibromyalgia and its symptoms.
Use the revised fibromyalgia impact questionnaire to assess patient progress and response to treatment approaches.
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present. Albert Einstein College of Medicine and MCM Education. staff have no conflicts of interest with commercial interests related directly or indirectly to this educational activity.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product not yet approved for use in the United States.
Dr. Staud discloses that he has received grant/research funding from Pfizer Inc. and Forest Laboratories.
Dr. Barland has no disclosures.
The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests other than the following:
Steven Jay Feld, or a member of his household, own securities in: Bioheart Inc.; Chelsea Therapeutics, Inc.; and Pharmacopeia, Inc.
Kathleen Hines (MCM Education medical editor) has no disclosures. Credit Statements
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine, Montefiore Medical Center and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit is awarded to participants who score 60% or better on the post-test.
This activity will take approximately 30 minutes to complete. Commercial Support Statements
This activity is supported by an educational grant from Pfizer Inc.
There are no fees for participating in or receiving credit for this online educational activity.
This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity.
Review the intended audience, learning objectives, and author disclosures.
Study the educational content online.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
To access this activity users will need
• A computer with an Internet connection.
• Internet Explorer 6.x or higher, Firefox 2.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser. Certificate Fee
Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, the Healthcare Professional Pain Network, and MCM Education.
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, the Healthcare Professional Pain Network, or Pfizer Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.